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Introduction
Oxidative stress has been implicated in the pathogenesis of
a number of autoimmune diseases including rheumatoid
arthritis. The antioxidant superoxide dismutase (SOD) is
one of the most important enzymes involved in combating
oxidative stress. It exerts its protective effect by neutraliz-
ing free radicals to form oxygen and hydrogen peroxide.
Objectives
The aim of the present study was to measure SOD activity
in juvenile idiopathic arthritis (JIA) patients and to assess
whether these levels are influenced by disease activity or
JIA subtype.
Methods
Serum SOD activity was measured in 166 pediatric and
adolescent JIA patients attending Rheumatology clinics at
Great Ormond Street Hospital and University College
London Hospital and in 17 healthy controls (HC) using a
commercial colorimetric assay. Median age at sampling
was 16.37 [IQR 10.41-18.04] years for JIA patients and
14.78 [IQR 10.22-23.03] for HC). Median age of JIA onset
was 5.68 years [IQR 2.30-11.23]. Female:male ratio was
95:71 (57.2% female) in JIA patients and 11:5 (64.7%
female) in HC. Similar numbers of patients for each sub-
type were included (oligoarticular n = 24, extended oli-
goarticular n = 27, polyarticular n = 37, systemic-onset
n = 42, enthesitis-related n = 33) with the exception of
psoriatic arthritis (n = 3). Disease activity was defined by
presence of swollen joints and an erythrocyte sedimenta-
tion rate (ESR) greater or equal to 20 mm/hr. Inactive
patients were those with no swollen joints and an ESR less
than 20 mm/hr. Patients who did not fulfill both criteria
were excluded from analysis relating to disease activity.
Results
SOD activity was shown to be elevated in JIA patients
(median = 6.38 U/ml [IQR 4.83-8.70]) compared to con-
trols (median = 4.03 U/ml [IQR 2.18-6.48]) across all
subtypes (p = 0.0009). There was no statistically signifi-
cant difference in SOD activity between subtypes. No dif-
ference in SOD activity was observed between patients
with active disease and those with inactive disease and
SOD activity did not change depending on drug treat-
ment. However, SOD activity did change with anti-
nuclear antigen (ANA) status, with ANA positive patients
having elevated SOD levels (median = 7.22 U/ml [IQR
5.08-9.64]) compared to those who were ANA negative
(median = 5.95 U/ml [IQR 4.63-7.98]) (p = 0.022).
Conclusion
In conclusion, elevated activity of the antioxidant SOD
may be a response to increased oxidative stress in JIA.
However, it does not seemingly represent a useful biomar-
ker of disease activity. The association with ANA is inter-
esting and we are currently investigating whether SOD
levels correlate with uveitis.
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